Mr. Khaled Khan, the Chairman-cum-Managing Director of Fermish Clinical Technologies Pvt.  Ltd., is a well known pharmaceutical consultant. Mr. Khan is also one of India’s leading regulatory consultants.

With the help of his interactions with the prestigious office of Drug Controller General of India, Mr. Khaled Khan has been involved actively in the championing of drug development throughout India over the past 17 years. Mr. Khan has also managed to make his name in the field of medicine by making constant efforts to reach towards the optimum level of professional and qualitative services.

Mr. Khan has completed his M. Pharm (Pharmacology), B.Pharm, D.Pharm from the Hamdard College of Pharmacy (University of Delhi) in the years 1989, 1987 and 1984 respectively.

Mr. Khan's primary occupation is to work with pharmaceutical companies to ensure the successful completion of regulatory submissions and help them gain regulatory approval. His other areas of expertise and experience are technology transfer, licensing, formulation development and clinical research. Beginning with the initial drug development conception, Mr. Khan plays a vital role in the entire process of drug development and approval in India.

Well known amongst the Indian Pharmaceutical Industry as a hard core sincere and honest professional in the area of regulatory affairs and clinical research, Mr. Khaled Khan is in course of completing his Doctorate in Pharmaceutical Sciences with a subject titled “Comparative Studies of Regulatory Systems”. This thesis pertains to a new drug approval between India and Developed Countries. Mr. Khan currently works independently as a consultant with few respected Pharmaceutical / medical device companies and Clinical Research Organizations operating in the area of clinical investigations.